Sivapriya Kirubakaran

Statistics

Publications

Citations

653

H-Index

Active since

2010

Affiliations

Indian Institute of Technology Gandhinagar(Current)

Brigham and Women's Hospital

Louisiana State University Health Sciences Center Shreveport

Harvard University

Dana-Farber Cancer Institute

Sivapriya Kirubakaran is an author at Indian Institute of Technology Gandhinagar specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2010–2024

Publications

Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR

Qingsong Liu, Chunxiao Xu, Sivapriya Kirubakaran et al. · Cancer Research · 2013 · 213 citations · Full text

Medicine, Oncology, Pharmacology +13

Kinome-wide Selectivity Profiling of ATP-competitive Mammalian Target of Rapamycin (mTOR) Inhibitors and Characterization of Their Binding Kinetics

Qingsong Liu, Sivapriya Kirubakaran, Wooyoung Hur et al. · Journal of Biological Chemistry · 2012 · 104 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

The Structural Basis of Cryptosporidium-Specific IMP Dehydrogenase Inhibitor Selectivity

Iain Macpherson, Sivapriya Kirubakaran, Suresh Kumar Gorla et al. · Journal of the American Chemical Society · 2010 · 66 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +14

Structure–activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH

Sivapriya Kirubakaran, Suresh Kumar Gorla, Lisa Sharling et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy

Vibha Singh, Siddhant Bhoir, Rupesh V. Chikhale et al. · iScience · 2020 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 18